Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Combined Urinary Procedure Used to Diagnosis Mucopolysaccharidoses

By LabMedica International staff writers
Posted on 18 Jan 2017
Mucopolysaccharidoses (MPS) are a group of rare genetic disorders of glycosaminoglycan (GAG) metabolism caused by the deficiency of one of the lysosomal enzymes required for GAG degradation. The diseases are characterized by the accumulation of undegraded glycosaminoglycans in lysosomes in multiple organs and by their excretion in high amounts in urine.

An early and accurate diagnosis of MPS is critical not only to permit disease-specific genetic counselling but also to guide appropriate supportive care and disease-specific therapy, when available. The first steps in the laboratory diagnosis of MPS suspected patients are based on the quantitative and qualitative analysis of urinary GAGs consisting of their quantitative as well as qualitative evaluation.

Scientists at the Marche Polytechnic University carried out retrospective study analyzing 2,154 normal urine samples and 210 samples from 73 patients affected by different types of Mucopolysaccharidoses. The glycosaminoglycans were quantified by a dimethylmethylene blue (DMB) method and size-fractionated by a modified one-dimensional electrophoresis method.

Untreated urine samples were analyzed for total GAG content using the DMB test and spectrophotometric measurements were recorded on a Shimadzu UV–visible 1601 spectrophotometer. Creatinine concentration was determined on 100 μL of urine by a Spotchem SP-4430 analyzer. Electrophoretic GAG characterization was performed using cellulose acetate membranes.

The investigators found that the combination of the two methods allowed identifying all the patients affected by the different types of Mucopolysaccharidosis with 100% sensitivity and specificity. The differences between the means displayed according to age values of the control samples and the corresponding values of the MPS patients are statistically significant in all groups with at least more than three samples. Out of 2,154 samples of normal subjects, an increased GAG concentration was found in 259 (12%) samples; however, none of them showed a pathological pattern at the electrophoresis.

The authors concluded that that the combined use of DMB test and electrophoresis allows the identification of all patients affected by MPS with 100% sensitivity and specificity. Moreover, this diagnostic approach provides useful information to proceed with further laboratory and diagnostic confirmatory tests, from enzyme assay to genetic analyses. The study was published in the January 2017 issue of the journal Clinica Chimica Acta.


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Anti-HHV-6 IgM Assay
anti-HHV-6 IgM ELISA (semiquant.)
New
Total 25-Hydroxyvitamin D₂ & D₃ Assay
Total 25-Hydroxyvitamin D₂ & D₃ Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.